Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Related Articles by Review for PubMed (Select 19066876)

1.

Effect of two sports drinks on urinary lithogenicity.

Goodman JW, Asplin JR, Goldfarb DS.

Urol Res. 2009 Feb;37(1):41-6. doi: 10.1007/s00240-008-0166-0. Epub 2008 Dec 10.

PMID:
19066876
2.

Urinary alkalization for the treatment of uric acid nephrolithiasis.

Cicerello E, Merlo F, Maccatrozzo L.

Arch Ital Urol Androl. 2010 Sep;82(3):145-8. Review.

PMID:
21121431
3.

Dietary therapy for patients with hypocitraturic nephrolithiasis.

Kurtz MP, Eisner BH.

Nat Rev Urol. 2011 Mar;8(3):146-52. doi: 10.1038/nrurol.2011.9. Epub 2011 Feb 15. Review.

PMID:
21321574
4.

Management of primary hyperoxaluria: efficacy of oral citrate administration.

Leumann E, Hoppe B, Neuhaus T.

Pediatr Nephrol. 1993 Apr;7(2):207-11. Review.

PMID:
8476722
5.

Update on the medical management of stone disease.

Tracy CR, Pearle MS.

Curr Opin Urol. 2009 Mar;19(2):200-4. doi: 10.1097/MOU.0b013e328323a81d. Review.

PMID:
19188774
6.

Indications for a medium mineral high bicarbonate water (Cerelia) in urology.

Bertaccini A, Borghesi M.

Arch Ital Urol Androl. 2009 Sep;81(3):192-4. Review.

PMID:
19911684
7.

[Citrate and renal stones].

del Valle EE, Spivacow FR, Negri AL.

Medicina (B Aires). 2013;73(4):363-8. Review. Spanish.

8.

Physiology of acid-base balance: links with kidney stone prevention.

Halperin ML, Cheema Dhadli S, Kamel KS.

Semin Nephrol. 2006 Nov;26(6):441-6. Review.

PMID:
17275581
9.

Urolithiasis in adults. Clinical and biochemical aspects.

Abdel-Halim RE.

Saudi Med J. 2005 May;26(5):705-13. Review.

PMID:
15951854
10.
11.

Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.

Lewandowski S, Rodgers AL.

Clin Chim Acta. 2004 Jul;345(1-2):17-34. Review.

PMID:
15193974
12.

Recurrent uric acid stones.

Kamel KS, Cheema-Dhadli S, Shafiee MA, Davids MR, Halperin ML.

QJM. 2005 Jan;98(1):57-68. Review.

14.

Metabolic syndrome and uric acid nephrolithiasis.

Sakhaee K, Maalouf NM.

Semin Nephrol. 2008 Mar;28(2):174-80. doi: 10.1016/j.semnephrol.2008.01.010. Review.

PMID:
18359398
15.

Preventive treatment of nephrolithiasis with alkali citrate--a critical review.

Mattle D, Hess B.

Urol Res. 2005 May;33(2):73-9. Epub 2005 May 4. Review.

PMID:
15875173
16.

Low urinary citrate: an overview.

Zacchia M, Preisig P.

J Nephrol. 2010 Nov-Dec;23 Suppl 16:S49-56. Review.

PMID:
21170889
17.

[Nephrolithiasis in patients with intestinal diseases].

Cirillo M, Iudici M, Marcarelli F, Laudato M, Zincone F.

G Ital Nefrol. 2008 Jan-Feb;25(1):42-8. Review. Italian.

PMID:
18264917
18.

Pharmacotherapy of kidney stones.

Pak CY.

Expert Opin Pharmacother. 2008 Jun;9(9):1509-18. doi: 10.1517/14656566.9.9.1509 . Review.

PMID:
18518781
19.

Prevention of stone disease.

Porena M, Guiggi P, Micheli C.

Urol Int. 2007;79 Suppl 1:37-46. Review.

PMID:
17726351
20.

Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser.

Hoy SM, Scott LJ, Wagstaff AJ.

Drugs. 2009;69(1):123-36. doi: 10.2165/00003495-200969010-00009. Review.

PMID:
19192941
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk